Fasting has shown its potential to reduce colorectal cancer risk by triggering cellular changes that may slow tumor growth, with a study demonstrating a 20% improvement in overall survival. However, ...
Emerging evidence suggests that fasting could play a role in the fight against cancer. However, studies to date have been relatively small and results have been mixed, leaving an unclear picture of ...
Hosted on MSN
Why fasting won't cleanse your body—or beat cancer
Every few months, a new "miracle cure" for cancer trends on social media. From superfoods and supplements to extreme diets, the promises are always bold—and almost always misleading. The latest claim ...
Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical results published Aug ...
Among the 10 patients with CCNE1-amplified high grade serous ovarian cancer treated with INX-315, 20% achieved a partial response and 80% achieved stable disease. The Food and Drug Administration (FDA ...
TARPON SPRINGS, Fla., August 26, 2025 -- Allarity Therapeutics, Inc. (ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT ...
ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA damage response. 3,4 Upon PARG inhibition, the agent is intended to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results